Search results
Results From The WOW.Com Content Network
A neonatal withdrawal syndrome, sometimes severe, can occur when the mother had taken benzodiazepines, especially during the third trimester. Symptoms include hypotonia, apnoeic spells, cyanosis, impaired metabolic responses to cold stress, and seizures. The neonatal benzodiazepine withdrawal syndrome has been reported to persist from hours to ...
Benzodiazepines, cyproheptadine [ 1] Frequency. Unknown [ 3] Serotonin syndrome ( SS) is a group of symptoms that may occur with the use of certain serotonergic medications or drugs. [ 1] The symptoms can range from mild to severe, and are potentially fatal. [ 4][ 5][ 2] Symptoms in mild cases include high blood pressure and a fast heart rate ...
Quetiapine, sold under the brand name Seroquel among others, is an atypical antipsychotic medication used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder. [9] [10] Despite being widely used as a sleep aid due to its sedating effect, the benefits of such use may not outweigh its undesirable side effects. [11]
To access these savings, there’s an annual membership fee of $20 for individuals and $35 for families. Kroger: The Kroger Rx Savings Club offers select medications for $6 or less for a 1-month ...
AstraZeneca (AZN) divests commercial rights to its schizophrenia and bipolar disorder medicines Seroquel/Seroquel XR in the United States and Canada to Cheplapharm Arzneimittel GmbH.
One of the world's largest drug companies, AstraZeneca, agreed to pay $520 million to settle a U.S. government lawsuit claiming the company encouraged doctors to prescribe an anti-psychotic drug ...
According to the European Medicines Agency (EMA), as of 28 March 2021, the reported number of cases of embolic and thrombotic events after vaccination is lower than the rate of such events in the general population overall. However, the specific syndrome - of embolic and thrombotic events in combination with low levels of blood platelets ...
AstraZeneca agreed to pay $3.1 million to settle a New York State Attorney General's lawsuit saying the British pharmaceutical company improperly promoted and marketed the schizophrenia drug ...